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growth by down-regulating S6K activity upstream of TSC in
Drosophila
Abstract
Diverse extrinsic and intrinsic cues must be integrated within a developing organism to ensure
appropriate growth at the cellular and organismal level. In Drosophila, the insulin receptor/TOR/S6K
signaling network plays a fundamental role in the control of metabolism and cell growth. Here we show
that scylla and charybdis, two homologous genes identified as growth suppressors in an EP
(enhancer/promoter) overexpression screen, act as negative regulators of growth. The simultaneous loss
of both genes generates flies that are more susceptible to reduced oxygen concentrations (hypoxia) and
that show mild overgrowth phenotypes. Conversely, scylla or charybdis overactivation reduces growth.
Growth inhibition is associated with a reduction in S6K but not PKB/Akt activity. Together, genetic and
biochemical analysis places Scylla/Charybdis downstream of PKB and upstream of TSC. Furthermore,
we show that scylla and charybdis are induced under hypoxic conditions and that scylla is a target of
Drosophila HIF-1 (hypoxia-inducible factor-1) like its mammalian counterpart RTP801/REDD1, thus
establishing a potential cross-talk between growth and oxygen sensing.
doi:10.1101/gad.322704 
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The hypoxia-induced paralogs Scylla
and Charybdis inhibit growth
by down-regulating S6K activity
upstream of TSC in Drosophila
Jan H. Reiling and Ernst Hafen1
Zoologisches Institut, Universität Zürich, CH-8057 Zürich, Switzerland
Diverse extrinsic and intrinsic cues must be integrated within a developing organism to ensure appropriate
growth at the cellular and organismal level. In Drosophila, the insulin receptor/TOR/S6K signaling network
plays a fundamental role in the control of metabolism and cell growth. Here we show that scylla and
charybdis, two homologous genes identified as growth suppressors in an EP (enhancer/promoter)
overexpression screen, act as negative regulators of growth. The simultaneous loss of both genes generates
flies that are more susceptible to reduced oxygen concentrations (hypoxia) and that show mild overgrowth
phenotypes. Conversely, scylla or charybdis overactivation reduces growth. Growth inhibition is associated
with a reduction in S6K but not PKB/Akt activity. Together, genetic and biochemical analysis places
Scylla/Charybdis downstream of PKB and upstream of TSC. Furthermore, we show that scylla and charybdis
are induced under hypoxic conditions and that scylla is a target of Drosophila HIF-1 (hypoxia-inducible
factor-1) like its mammalian counterpart RTP801/REDD1, thus establishing a potential cross-talk between
growth and oxygen sensing.
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The control of growth in response to intrinsic and ex-
trinsic factors is important for the development of every
organism. Deregulated growth can have devastating con-
sequences such as tumor formation. The evolutionarily
conserved Insulin/IGF receptor (Inr)/Target of Rapamy-
cin (TOR) signaling network plays an important role in
modulating growth, metabolism, reproduction, and life
span in response to intracellular and extracellular signals
in species ranging from invertebrates to humans (Garo-
falo 2002; Jacinto and Hall 2003). In Drosophila, viable
mutant combinations of positive components of the
Drosophila Inr cascade such as Inr, chico (the homolog of
vertebrate IRS1-4), PKB (Protein kinase B, also known as
Akt) and PDK1 (3-phosphoinositide-dependent protein
kinase-1) lead to developmentally delayed and propor-
tionally reduced small flies, displaying a reduction in
cell size and number (Bohni et al. 1999; Brogiolo et al.
2001; Rintelen et al. 2001). On the other hand, loss of
PTEN (phosphatase and tensin homolog on chromosome
ten), which antagonizes PI3K activity by dephosphory-
lating the 3-position of phosphoinositides, leads to hy-
pertrophy and hyperplasia (Goberdhan et al. 1999; Huang
et al. 1999; Gao et al. 2000). In humans, loss of the tumor
suppressor PTEN is observed frequently in glioblasto-
mas, prostate cancers, and endometrial cancers, and
PTEN germline mutations are linked to dominant ham-
artoma syndromes like Cowden syndrome, Lhermitte-
Duclose disease, Proteus syndrome, and Bannayan-Zo-
nana syndrome (Sulis and Parsons 2003). Genetic studies
in Drosophila indicate that PKB has a crucial role in
signaling downstream of PTEN since flies completely
lacking PTEN function can be rescued to viability by
lowering PKB activity (Stocker et al. 2002).
The TOR/S6K (S6 kinase) branch of the growth modu-
latory network is negatively regulated by the tumor sup-
pressor Tsc1 (hamartin)/Tsc2 (tuberin) complex. Tuber-
ous sclerosis complex (TSC) is an autosomal-dominant
disorder characterized by the formation of hamartomas,
benign tumors that arise in various tissues (Pan et al.
2004). In Drosophila, cells devoid of Tsc1/Tsc2 function
are increased in size (Gao and Pan 2001; Potter et al.
2001; Tapon et al. 2001). Tsc2 and, more weakly, Tsc1
were found to physically associate with dTOR, thereby
inhibiting dTOR kinase activity (Gao et al. 2002). Other
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studies reported an inhibitory role of PKB on Tsc1–Tsc2
by PKB-mediated phosphorylation of Tsc2 (Inoki et al.
2002; Manning et al. 2002). Recently, the small GTPase
Rheb (Ras homolog enriched in brain) has been identified
as a new positive growth effector acting downstream of
Tsc1–Tsc2 and upstream of TOR. Mechanistically, Tsc2
acts as GTPase-activating protein (GAP) toward Rheb
(Garami et al. 2003; Inoki et al. 2003a; Saucedo et al.
2003; Stocker et al. 2003; Tee et al. 2003; Zhang et al.
2003). The molecular mechanism how Rheb relays the
signal to TOR is currently unknown. dTOR mutants
show a growth deficit that is more pronounced in en-
doreplicative tissues than in mitotic tissues (Oldham et
al. 2000; Zhang et al. 2000). An effector of mTOR is S6K,
which upon activation by mTOR phosphorylates ribo-
somal protein S6. S6K-mediated S6 phosphorylation
has been thought to lead to a preferential translation of
mRNAs encoding ribosomal proteins and proteins of the
translational apparatus although the significance of this
S6K function has been questioned recently (Tang et al.
2001; Stolovich et al. 2002; Pende et al. 2004). Inr/TOR
signaling activity culminates in the regulation of trans-
lation rate by controlling S6K and the translational re-
pressor 4E-BP1 (Gingras et al. 2004). S6K mutant flies are
small but in contrast to mutants of the Inr pathway, only
cell size is reduced without a change in cell number
(Montagne et al. 1999). Therefore, loss of S6K function
reduces growth and body size to a lesser extent than loss
of other positive components acting further upstream in
the cascade.
Growth is modulated by extrinsic factors such as nu-
trients, temperature, and hypoxia (Palos and Blasko
1979; Frazier et al. 2001; Azevedo et al. 2002). However,
their link to the Inr/TOR signaling network are not well
defined. Although it is known that starvation results in
a reduction in the levels of insulin-like peptides and a
reduction in S6K activity in Drosophila (Oldham et al.
2000; Ikeya et al. 2002), little is known about whether
temperature or hypoxia regulates the activity of this
pathway. It is conceivable that mutations in genes cod-
ing for factors mediating the modulation of growth in
response to external stimuli have escaped detection be-
cause they do not exhibit a very strong phenotype under
standard culture conditions. For example, overexpres-
sion of the Forkhead transcription factor FOXO3a, the
human homolog of Drosophila dFOXO, produces a very
subtle small eye phenotype under normal nutrient con-
ditions. Under starvation, however, this phenotype is
massively exacerbated, inducing a further eye size reduc-
tion and cell death. Furthermore, dFOXO mutant flies
are viable and do not show an (over)growth phenotype in
an otherwise wild-type background under normal condi-
tions (Junger et al. 2003).
Genes like dFOXO were missed in genetic loss-of-
function screens aimed at identifying growth-regulatory
genes (1) because they have only mild or missing mutant
phenotypes under normal conditions and/or (2) because
their function is masked by redundancy.
Genes acting in a redundant manner can be identified
in a complementary gain-of-function approach using EP
(enhancer/promoter) elements (Rorth 1996). Screening
>4000 novel EP lines, we found two insertions in the
scylla locus as suppressors of a PKB/PDK1-dependent
eye overgrowth phenotype. We identified a second gene
in the Drosophila genome with homology to scylla
named charybdis. Homologs of these genes also exist in
mammals, and they have been implicated in the re-
sponse of a cell to hypoxia or more generally as stress-
induced genes having either pro- or anti-apoptotic func-
tions. We present evidence that scylla and charybdis,
like some of their mammalian homologs, are induced by
hypoxia and that Scylla and Charybdis act as partially
redundant negative regulators of growth by controlling
S6K but not PKB activity.
Results
Identification of scylla and charybdis
In order to identify novel genes involved in growth regu-
lation by the Inr/TOR pathway, we performed an EP
overexpression screen using a double-headed EP ele-
ment. We used a genetically sensitized system involving
coexpression of PKB and PDK1 (achieved by using EP837
that drives endogenous PDK1) in the eye, which leads to
a big eye phenotype (Fig. 1B). Pilot experiments demon-
strated that overexpression of PTEN or a dominant-nega-
tive version of the catalytic subunit of Drosophila PI3K,
Dp110, were not able to suppress the PKB/PDK1-depen-
dent phenotype. Thus, our screening system is likely to
identify components acting downstream of or in parallel
to PKB/PDK1. For example, coexpression of Tsc1/Tsc2
strongly suppresses the phenotype of our tester flies (data
not shown).
We identified two EP insertions (EP22.1, hereafter
named EPscy, and EP9.85) in the scylla locus as suppres-
sors of the PKB/PDK1 bulging eye phenotype (Fig. 1C).
BLASTP search with the Scylla amino acid sequence re-
vealed another homologous protein encoded in the Dro-
sophila genome termed Charybdis. scylla (scy, CG7590)
and charybdis (char, CG7533) are separated by ∼232 kb
of genomic DNA. Their gene products share a high de-
gree of homology (38% identity, 49% similarity), sugges-
tive of a gene duplication event (Fig. 1F,G). We checked
whether charybdis overexpression would behave simi-
larly to scylla in the PKB/PDK1 overexpression assay
using EP1035 (hereafter named EPchar). Indeed, the big
eye phenotype of the tester system is also suppressed by
EPchar (Fig. 1D). UAS transgenes with either the scylla
or charybdis cDNA recapitulate the suppression pheno-
type of the corresponding EP element (data not shown).
Coexpression of scylla and charybdis further amelio-
rates the suppression phenotype to a nearly wild-type
situation (Fig. 1E). Notably, scylla or charybdis overex-
pression on their own using a panel of different eye/wing
Gal4 drivers reduced adult organ size. Coexpression of
the caspase inhibitors p35 or DIAP1 did not rescue the
small eye phenotype induced by expression of either
scylla or charybdis in the eye. Moreover, no elevated cell
death in eye imaginal disks overexpressing scylla/
Reiling and Hafen
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charybdis under control of the GMR-Gal4 driver was
observed by acridine orange staining (data not shown).
This suggests that apoptosis is not the cause for the eye
size reduction. Thus, scylla and charybdis overexpres-
sion antagonizes the growth-promoting effects of PKB/
PDK1 and is sufficient to negatively regulate growth.
scylla and charybdis are both expressed during em-
bryogenesis in dynamic, partially overlapping patterns.
In contrast to the broadly expressed scylla mRNA,
charybdis transcripts are predominantly restricted to
neurons of the CNS and PNS as assessed by mRNA in
situ hybridization. During late larval stages scylla
mRNA is uniformly expressed without apparent tissue-
specific distribution, whereas charybdis mRNA expres-
sion could not be detected in third instar imaginal disks
(data not shown).
Scylla and Charybdis belong to an evolutionarily
conserved protein family
scylla codes for a 280-amino acid polypeptide with a pre-
dicted molecular weight (MW) of ∼31 kDa, and the
Charybdis protein contains 299 amino acid residues
(MW ∼32 kDa). Since EP9.85 is located in the coding
region of scylla, thus generating a Scylla protein with an
N-terminal truncation of 12 amino acids, we tested
whether a UAS-scy transgene encoding the truncated
form of Scylla behaves as the full-length protein. Over-
expression of UAS-scy1–12 and UAS-scywt showed the
same effects as EPscy (data not shown), indicating that
amino acids 1–12 are dispensable for the growth-sup-
pressing function of Scylla.
Homologs of Scylla/Charybdis exist throughout the
animal kingdom including humans, rat, mouse, Xeno-
pus, and zebrafish. Reminiscent of the situation in Dro-
sophila, mammals possess several paralogous proteins
with homology to Scylla/Charybdis. At least two ho-
mologs (RTP801/REDD1 and FLJ3691, a hypothetical
protein presumably corresponding to REDD2 [Ellisen et
al. 2002]) exist in humans, two (RTP801 and SMHS1) in
rat, and three (RTP801L, Dig2, and SMHS1) in mice. The
overall homology is highest toward the C terminus (Fig.
1G). Charybdis contains a predicted coiled-coil structure
(amino acids 168–188).
In mammals, RTP801/REDD1 and other members of
the family are induced upon various forms of cellular
stress including hypoxia, DNA damage, and dexametha-
sone treatment (Ellisen et al. 2002; Shoshani et al. 2002;
Wang et al. 2003). In fact, RTP801/REDD1 is a direct
target of HIF-1, a heterodimeric transcription factor that
plays a pivotal role for survival in response to hypoxia
(Shoshani et al. 2002). Furthermore, RTP801/REDD1 is
controlled by p53 and p63 (Ellisen et al. 2002). Depend-
ing on the experimental setup and cell context, RTP801
overexpression either inhibits or increases apoptosis,
suggesting a complex regulation and/or dependence on
the developmental program of the cell (Shoshani et al.
2002).
Scylla and Charybdis inhibit growth and are
important under hypoxic conditions
To investigate the function of Scylla and Charybdis in
more detail, we generated loss-of-function mutations in
both genes and complemented the analysis with overex-
pression studies.
Partial scylla deletions were obtained by imprecise ex-
cisions of EP9.85, which is integrated in the scylla open
reading frame (ORF) and therefore already represents a
scylla allele (hereafter named scyEP9.85) (Fig. 1F). For
charybdis, we used a local hop strategy of EPchar to
obtain char180, constituting a new EP insertion
(EP1035*) in the charybdis 5-untranslated region (UTR)
plus the original EPchar (see Materials and Methods).
Quantitative real time-PCR showed that in char180 ho-
mozygotes, charybdis mRNA expression is decreased to
∼25% of wild-type levels (data not shown). We assume
Figure 1. Overexpression of scylla and its paralog charybdis
suppresses the hyperactivity of the Inr pathway. (A–E) scylla (C)
and/or charybdis (D) overexpression (achieved by EPscy and
EPchar, respectively) suppress the PKB/PDK1-dependent big
eye phenotype (B). Genotypes: y w; GMR-Gal4/+ (A,A); y w;
GMR-Gal4 UAS-PKB/+; EP837 (≈UAS-PDK1)/+ (B,B); y w;
GMR-Gal4 UAS-PKB/+; EP837/EPscy (C,C); y w; GMR-Gal4
UAS-PKB/+; EP837/EPchar (D,D); y w; GMR-Gal4, UAS-PKB/+;
EP837/EPscy EPchar (E,E). (F) Genomic organization of scylla
and charybdis and corresponding mutant alleles. (G) Several
homologs of Scylla/Charybdis are present in humans (h), rat (r),
mouse (m), Xenopus (x), and zebrafish (z). Charybdis bears a
coiled-coil domain (amino acids 168–188) not predicted in
Scylla. However, the evolutionarily most highly conserved, C-
terminal part of the gene family lacks similarities to known
protein domains.
SCY and CHAR inhibit S6K-mediated growth
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that this charybdis allele is a strong hypomorph, as
mRNA levels were only slightly more reduced (to 23%
or 15%, respectively) when RNA was extracted from
flies heterozygous for char180 over either one of two in-
dependent deficiencies uncovering charybdis and scylla
(data not shown).
All scylla mutant combinations and the char180 ho-
mozygotes are viable and fertile without apparent mu-
tant phenotype. scylla and char180 mutant animals have
the same weight as control flies. Measurement of wing
size and hair density in the adult wing of scylla mutants
revealed no differences in cell size and cell number as
compared to control animals (data not shown). We cre-
ated scylla loss-of-function clones in imaginal disks us-
ing FLP/FRT-mediated mitotic recombination to test the
effect on growth properties of the mutant tissue. One
would expect a growth advantage of cells in clones lack-
ing a bona fide negative growth regulator, as is the case
for PTEN. However, larval scylla mutant clones were the
same size as their wild-type sister clones. Likewise,
clones obtained in adult eyes revealed no increase in cell
size of scylla or char180 mutant ommatidia (data not
shown). Thus, loss of Scylla or Charybdis function is
dispensable for growth under normal conditions. It is
conceivable that Scylla and Charybdis act in a redundant
manner. Therefore, it was important to create scylla
charybdis double mutants.
We combined char180 with three of our scylla alleles
by meiotic recombination. All double-mutant scylla
charybdis combinations produced viable adult flies.
Weight analysis of heteroallelic scylla charybdis flies
demonstrated that simultaneous loss of Scylla and
Charybdis significantly increases body weight. Consis-
tent results were obtained by combining one copy of
scyEP9.85/31/113 char180 and the deficiency Df(3L)vin4
uncovering scylla and charybdis. Mutant females were
on average 6%–23% and males 9%–17% heavier than
control flies (Fig. 2A; data not shown). Conversely,
ubiquitous scylla/charybdis overexpression using the
Act5CGal4 driver generated flies that are decreased in
size and weight (15.1% using EPscy and 14.3% using
UAS-char#53) (Fig. 2B, data only shown for males). The
majority of scylla/charybdis-overexpressing flies eclosed
with a minor delay (0.5–1 d) (data not shown).
To assess whether charybdis/scylla overexpression af-
fects cell size, we generated scylla and charybdis gain-
of-function flip-out clones in the eye, marked by the ab-
sence of the red pigment. A moderate reduction in cell
size was observed in cells overexpressing scylla or
charybdis (Fig. 2C,D). Ommatidia overexpressing scylla
Figure 2. Scylla and Charybdis inhibit growth. (A) Simulta-
neous loss of Scylla and Charybdis leads to an increase in body
weight. Control flies (black bars) are represented by either of the
two possible double mutants over the TM3 balancer chromo-
some (first three black columns) or the deficiency chromosome
(Df(3L)vin4) over TM3 (three last black columns) and were de-
rived from the same vial as the heteroallelic double-mutant
flies, p < 0.009 using Student’s t-test (two-tailed). Between 32
and 65 flies were weighed per genotype. Genotypes (only white
bars indicated) are as follows: y w; scy113 char180/scyEP9.85
char180 (1); y w; scy31 char180/scyEP9.85 char180 (2); y w; scy31
char180/scy113 char180 (3); y w/+; scyEP9.85 char180/Df(3L)vin4
(4); y w/+; scy113 char180/Df(3L)vin4 (5); y w/+; scy31 char180/
Df(3L)vin4 (6). (B) Ubiquitous scylla and charybdis overexpres-
sion generates smaller flies that have reduced body weights. In
all our overexpression studies, we obtained the strongest effects
using EPscy or UAS-char#53, driving scylla and charybdis, re-
spectively. A representative experiment of three independent
weighing analyses is shown (n = 35 for each genotype;
p < 0.0001 for UAS-scy#2, EPscy, UAS-char#53, and p < 0.02 for
EPchar). Data are only shown for males, but significant weight
reduction is also observed in females. Genotypes are as fol-
lows: y w; Act5CGal4/+ (control) (1); y w; UAS-scy#2/+;
Act5CGal4/+ (2); y w; Act5CGal4/EPscy (3); y w; Act5CGal4/
UAS-char#53 (4); y wAct5CGal4/EPchar (5). (C–F) Tangential
sections through the adult eye showing photoreceptor and as-
sociated ommatidial cells. Clones of cells either overexpressing
scylla/charybdis or lacking the function of both are recogniz-
able by the absence of red pigment. scylla-overexpressing cells
(C) or charybdis-overexpressing cells (D) in the eye are smaller
than neighboring wild-type cells, and no patterning defects are
observed. Conversely, scylla charybdis double-mutant cells
show a mild increase in cell size (E,F). Genotypes are as follows:
y w hsflp; GMR > w+ > Gal4/EPscy (C); y w hsflp; UAS-
char#56/+; GMR > w+ > Gal4/+ (D); y w hsflp; FRT80 scy113
char180/FRT80 w+ (E); y w hsflp; FRT80 scyEP9.85 char180/FRT80
w+ (F). (G,H) Quantification of wing cell size and cell number
of flies overexpressing scylla. Hair density in a defined square
area next to the junction of the posterior cross-vein and vein
five was determined, and from this number cell size was cal-
culated. The cell number corresponds to the ratio of total
wing area and cell size. scylla overexpression reduces only cell
size but not cell number. Black bars always represent the con-
trol (y w; Act5CGal4/+), and white bars represent scylla over-
expression (y w; Act5CGal4/EPscy). Numbers indicate the sex:
1 for males, and 2 for females. We analyzed 10 wings of each
genotype.
Reiling and Hafen
2882 GENES & DEVELOPMENT
 on May 15, 2006 www.genesdev.orgDownloaded from 
or charybdis exhibit no patterning defects. On the other
hand, simultaneous removal of Scylla and Charybdis in
clones of photoreceptor cells resulted in slightly enlarged
cells (Fig. 2E,F). Consistently, when most of the head
capsule and the eyes were made homozygous by means
of the eyflp/FRT system in an otherwise heterozygous
mutant background, a mild big head phenotype was gen-
erated in the double mutant but not in either single mu-
tant (Supplementary Fig. S1).
The gain-of-function clonal analysis in the eye showed
that cell size is reduced upon forced scylla/charybdis
expression, but it did not address the question whether
cell number is affected. To clarify this issue, the wing
size and cell number of flies that ubiquitously overex-
press scylla were measured. The insect wing is a double-
layered epithelial structure, and each cell in the wing
secretes a single hair (trichome). Therefore, by count-
ing the number of trichomes per defined area, hair den-
sity can be taken as a measure for cell number. Overall
wing size was reduced by ∼25% in males or ∼15% in
females overexpressing scylla (Fig. 2G). By extrapolat-
ing the number of cells per measured area, we found that
cell size is decreased by ∼29% in males and ∼21% in
females (Fig. 2H). We conclude that the size reduction
brought about by overexpressing scylla is caused by a
reduction in cell size. Cell density is even slightly in-
creased (5.8% in males, 7.6% in females) (data not
shown). Our data show that Scylla and Charybdis have a
growth-inhibitory role and that they share some func-
tional redundancy.
RTP801/REDD1 was shown to be induced by hypoxia
(Shoshani et al. 2002). This prompted us to investigate
the effects of hypoxia on the scylla charybdis double
mutants. scylla charybdis mutant larvae were raised on
normal food at room temperature in a hypoxia chamber
containing 9% oxygen during their entire development.
In general, control flies as well as scylla charybdis ho-
mozygotes were 3–4 d delayed in development under
these hypoxic conditions. However, whereas adult ho-
mozygous scylla charybdis double mutants could
readily be recovered under standard culture conditions in
normoxia, homozygous mutants of three independent
scylla charybdis allelic combinations (char180 in combi-
nation with scy31, scy113, or scyEP9.85) were strongly un-
derrepresented compared to normoxic conditions. We
also observed the appearance of an increased number of
dead pupae in the vials (data not shown). The scylla113
char180 double-mutant combination had the strongest
effect, and only two escapers (out of 326 scored flies)
hatched, whereas under normoxia flies with this geno-
type were recovered with nearly the expected Mendelian
ratio. The eclosed homozygotes raised under hypoxia did
not show obvious morphological defects.
Thus, whereas simultaneous loss of Scylla and
Charybdis under normoxic conditions results in a slight
increase in growth, their absence under reduced oxy-
gen concentrations severely compromises larval de-
velopment. This indicates that Scylla and Charybdis
have a critical function for survival under hypoxic
conditions.
scylla and charybdis are up-regulated under hypoxic
conditions and scylla is a target of Drosophila HIF-1
The transcription factor HIF-1 is the key regulator of
changes in gene expression in response to hypoxia
(Bruick 2003). It consists of two bHLH-PAS domain pro-
tein subunits (HIF-1 and HIF-1). Under conditions of
low oxygen, the HIF-1 protein complex is stabilized and
binds to Hypoxia Response Elements (HRE), short regu-
latory DNA sequences (core recognition sequence 5-
TACGTG-3) located in the genomic region of target
genes. Both the scylla and charybdis loci possess several
HREs. Since RTP801/REDD1, a mammalian homolog of
scylla and charybdis, is a direct target gene of HIF-1 and
is induced under hypoxic conditions, we wondered
whether this function is evolutionarily conserved. We
subjected wild-type larvae to hypoxia (between 2% and
5% O2) and checked for the induction of scylla and
charybdis expression. It is mainly the endoreplicative
tissue such as fat body, gut, salivary glands, and tracheae
that respond to changes in oxygen concentrations (Lav-
ista-Llanos et al. 2002). scylla mRNA expression was
up-regulated in the larval fat body and in the gut after
hypoxia (Fig. 3B; data not shown). charybdis, on the
other hand, was mildly induced in the midgut but not in
the fat body (Fig. 3D; data not shown). We also tested
whether hypoxia had an effect on Scylla protein levels
and distribution. To detect the endogenous Scylla pro-
tein, we took advantage of a transgenic Scylla-reporter
line (a so-called protein trap line). This protein trap line
bears a promoter-less green fluorescent protein (GFP)-
reporter transgene in the scylla locus generating a Scyl-
la–GFP fusion protein (Morin et al. 2001). Scylla–GFP is
expressed in most larval tissues. Under normoxic condi-
tions, nuclear accumulation of Scylla protein is observed
in some cells of the endoreplicative tissue (data not
shown). Consistent with our mRNA data, upon exposure
of third instar larvae to various hypoxia conditions, we
observed an up-regulation and nuclear localization of
Scylla protein in the fat body (data not shown) and in the
gut (Fig. 3K–P).
In Drosophila, the bHLH-PAS family comprises Period
(Per), Trachealess (Trh), Single-minded (Sim), Spineless
(Ss), Dysfusion (Dys), Tango (Tgo), and Similar (Sima).
Tgo is the ubiquitously expressed HIF-1 ortholog,
which dimerizes with any of the -subunits. Sima has
been shown to fulfill analogous functions to its mamma-
lian homolog HIF-1 (Lavista-Llanos et al. 2002).
To test whether scylla/charybdis transcription is regu-
lated by bHLH-PAS proteins that recognize the same
DNA stretch, we overexpressed sim, trh, or sima to-
gether with tgo using the Lsp2Gal4-driver that is active
specifically in the fat body during the third larval stage.
For Sima, we used a form lacking the oxygen-dependent
degradation domain (ODD), rendering it refractory to
proteolytic destruction under normoxic conditions.
Only the coexpression of tgo and sima induced scylla
but not charybdis expression as assessed by mRNA in
situ hybridization (Fig. 3G,J; data not shown). This does
not preclude, however, the possibility that charybdis is a
SCY and CHAR inhibit S6K-mediated growth
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target of Tgo–Sima as we detected its endogenous induc-
tion upon hypoxia only in the gut but not in the fat body.
Since neither expression of trh with tgo nor sim induced
scylla or charybdis expression, the regulation of scylla
by the Tgo–Sima heterodimer is specific. Thus, scylla
and charybdis, like their mammalian homolog RTP801/
REDD1, are induced by hypoxia, and at least scylla ap-
pears to be a direct target gene of the HIF-1 homolog
Tgo–Sima.
Scylla acts downstream of PKB but upstream of TSC
Although loss of Scylla function does not produce a mu-
tant phenotype on its own, we tested whether it would
alter the PKB/PDK1 overexpression eye phenotype. In-
deed, loss of Scylla function enhanced the PKB/PDK1
overgrowth phenotype (Fig. 4B,C). Thus, Scylla is essen-
tial for attenuating the increased growth in response to
hyperactivation of the Inr pathway. Furthermore, loss of
Scylla partially suppressed the growth reduction associ-
ated with reduced PKB function as assessed by compar-
ing weights of PKB3 single mutants to scy31 PKB3 double
mutants (Fig. 4D). In contrast, complete loss of Scylla in
a heteroallelic S6K combination did not rescue the S6K
single mutant phenotype indicating that S6K is epistatic
over scylla (Fig. 4E).
Moreover, overexpression of scylla and charybdis not
only suppressed the growth phenotype caused by over-
activation of the Inr pathway in the eye but to a certain
extent also rescued the lethality associated with the
ubiquitous increase in Inr pathway activity due to either
overexpression of PKB or loss of PTEN. scylla rescued
the male-specific lethality caused by ubiquitous expres-
sion of PKB and organismal lethality associated with the
partial but not complete loss of PTEN function. Simi-
larly, PKB-associated male lethality was also rescued by
charybdis overexpression (Supplementary Tables 1, 2).
This indicates that scylla and charybdis have the capac-
ity to act as potent negative regulators of insulin signal-
ing downstream of PKB and PDK1.
Several lines of evidence suggest that Scylla and
Charybdis act upstream of TSC and Rheb. Tsc1/2 mu-
tant flies can be rescued to adulthood by reducing S6K
signaling (Radimerski et al. 2002a), and a mere reduction
of one TOR copy in a Tsc1 mutant context results in a
rescue to the pupal stage (Gao et al. 2002). We examined
whether ubiquitous scylla overexpression could rescue
the larval lethality of heteroallelic Tsc1/2 mutant com-
binations (Tsc12G3/Tsc1Q87X and Tsc256/Tsc2192) using
the daGal4 or Act5CGal4 drivers in combination with a
UAS-scy transgene or EPscy at 18°C, 25°C, and 29°C.
Ubiquitous overexpression of scylla/charybdis in a
Tsc1/2 mutant background did in no case extend larval
development beyond first/second instar, and these larvae
died at the same time as Tsc1/2 mutants. Moreover, the
big head phenotype of Tsc2192 (and Tsc256) induced by
the eyflp/FRT system was not further enhanced in
scyEP9.85 char180 Tsc2 triple-mutant heads (Fig. 4F,G).
We have shown before (Supplementary Fig. S1) that
Figure 3. scylla and charybdis are induced by hypoxia, and scylla is a target of Drosophila HIF-1. (A–D) Larvae were incubated in a
hypoxia chamber for either 17 h under 2% O2 or for 7 h under 2.8% O2 conditions leading to the induction of scylla (B) and charybdis
(D) expression as assessed by mRNA in situ hybridization (ISH). Since scylla mRNA is detected in the gut under normoxia, it has been
difficult to assess whether scylla transcript levels are further induced under hypoxia (data not shown). (E–J) Directed coexpression of
Tgo and Sima in the fat body up-regulates scylla (G) but not charybdis (J) transcription. (F,I) Positive controls for scylla and charybdis,
respectively. (K–P) Scylla protein localizes to the nucleus and is up-regulated in the proventriculus (N) and the fat body (not shown)
in hypoxia. Genotypes are as follows: y w (A–D); y w; Lsp2Gal4/+ (E,H); y w; Lsp2Gal4/EPscy (F); y w; UAS-tgo/+; Lsp2Gal4/UAS-
sima692–863 (G,J); y w; Lsp2Gal4/EPchar (I). (K–P) Scylla fly trap larvae grown in normoxia (K–M) or incubated in hypoxia (2.8% O2
for 8 h; N–P).
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heads composed almost entirely of scylla charybdis
double-mutant cells are enlarged. Conversely, GMR-
Gal4-driven co-overexpression of Tsc1, Tsc2, and scylla
or charybdis in the eye did not further reduce the small
eye phenotype induced by coexpression of Tsc1 and Tsc2
on their own (data not shown). The absence of an addi-
tive growth effect upon loss of Tsc2, scylla, and charyb-
dis or overexpression of Tsc1/2 and scylla or charybdis
suggests that they function in the same pathway. These
results are consistent with the idea that Scylla and
Charybdis act upstream of the TSC complex (see also
next section). Our conclusion is further supported by
the fact that neither a Rheb-dependent bulging eye phe-
notype nor organismal lethality could be suppressed
by scylla/charybdis coexpression (Fig. 4H; data not
shown).
Scylla decreases S6K but not PKB activity
To test whether the placement of Scylla between PKB
and TSC can be corroborated biochemically, we investi-
gated the effect of scylla overexpression on PKB and S6K
activity.
We tested PKB activity of adult female heads overex-
pressing scylla or charybdis in conjunction with PKB
and PDK1 under control of the GMR-Gal4 enhancer. The
same experimental setup has previously been used to
demonstrate that PDK1 increases PKB activity (Cho et
al. 2001). Total fly head protein was extracted and PKB
activity was assayed by incorporation of 32P-labeled
phosphate into a synthetic PKB substrate (Crosstide,
CT). Although scylla/charybdis overexpression substan-
tially suppressed the PKB/PDK1-induced bulging eye
phenotype (Fig. 1C), PKB activity was not reduced in
these eyes (Fig. 5A). Moreover, PKB activity was also
unaffected in a scylla−/− background (Fig. 5B).
These results are consistent with the placement of
Scylla downstream of PKB. To test the effect of Scylla on
Figure 4. Scylla attenuates growth in response to elevated Inr
pathway activity downstream of PKB but upstream of TSC. (A–
C) A PKB/PDK1-overexpression eye phenotype is enhanced in a
scylla mutant background. Genotypes are as follows: y w (A,A);
y w; GMR-Gal4 UAS-PKB UAS-PDK1/+ (B,B); y w; GMR-Gal4
UAS-PKB UAS-PDK1/+; scylla31/scylla113 (C,C). (D) Loss of
scylla partially suppresses the weight loss of homozygous PKB3
mutants. Weight increase in the double mutants versus PKB3
single mutants is ∼6% (males) and 10% (females) for this ex-
periment. One representative of four independent weighing ex-
periments is shown; p < 0.0001, n = 60 (males) and 90 (females).
(E) No difference in body weight between a hypomorphic S6K
mutant combination and S6K scylla double mutants was ob-
served (n = 30). (F,G) scylla charybdis Tsc2 triple-mutant heads
resemble Tsc2 single mutants and do not show additive growth
effects, indicating that Scylla and Charybdis act upstream of
Tsc2. Genotypes are as follows: y w eyflp; FRT80 gig192/FRT80
cl3L w+ (F); y w eyflp; FRT80 scyEP9.85 char180 gig192/FRT80 cl3L
w+ (G). (H) A Rheb-dependent bulging eye phenotype cannot be
suppressed by scylla/charybdis coexpression. Genotypes are as
follows: y w; GMR-Gal4/+; EPRheb/+ (left); y w; GMR-Gal4/+;
EPRheb/EPscy EPchar (right).
Figure 5. Scylla reduces S6K activity, but neither Scylla nor
Charybdis down-regulates PKB activity. (A) Head extracts of
flies overexpressing PKB and PDK1 in conjunction with either
scylla or charybdis in the eye were assayed for PKB activity. No
reduction could be detected (experiment has been performed
twice). Genotypes are indicated above the autoradiograph. (CT)
Crosstide, a synthetic PKB substrate. (B) Eye-specific PKB/
PDK1 coexpression in a scylla mutant background does not lead
to elevated PKB activity (three experiments have been done). (C)
Ubiquitous scylla overexpression decreases S6K activity by
56% on average, p < 0.006. S6K activity of second instar larvae
was determined by the incorporation of radioactively labeled
phosphate into the H2B substrate. Control (Act5CGal4/+) ac-
tivity was set to 100%. Five independent experiments were per-
formed.
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S6K activity, second instar larvae expressing scylla un-
der the control of Act5CGal4 were collected, and larval
extracts were assayed for S6K activity. On average, S6K
activity was down-regulated by >50% (Fig. 5C). Al-
though there may also be a slight reduction in total S6K
protein levels, this effect cannot account for the much
stronger reduction in S6K activity. Taken together with
the genetic evidence presented above, these results
strongly support the argument that Scylla acts between
PKB and TSC to regulate S6K activity. Furthermore, in
an accompanying paper, Brugarolas et al. (2004) provide
direct biochemical evidence that a functional TSC com-
plex is required for RTP801/REDD1 to affect S6 phos-
phorylation. Altogether, these data indicate that Scylla
functions upstream of TSC.
Scylla and Charybdis prolong life span under
starvation conditions
Zinke et al. (2002) have performed a whole-genome DNA
microarray analysis of 2-d-old larvae (48 h AEL) grown on
normal food that were subsequently subjected to a star-
vation regime for different time periods. Under these
conditions, upon 12 h of starvation, scylla and charybdis
expression were found to be on average 6.3 times and 4.6
times up-regulated, respectively (downloadable Supple-
mental Material at http://www.fzk.de/embo). Therefore,
we tested the effects of starvation on the viability of
scylla and charybdis mutants, as well as on flies over-
expressing both genes by exposing adult flies to a water-
only diet. Various scylla heteroallelic combinations did
not show elevated susceptibility to starvation (data not
shown). However, char180 mutants lived significantly
shorter lives than control flies, suggesting that Charyb-
dis has a protective effect for the animal under nutrient-
deprived conditions (Fig. 6A). Strikingly, forced expres-
sion of scylla/charybdis extended mean life span by up
to twofold (Fig. 6B). We analyzed lipid and glycogen con-
tent of these flies to see whether energy stores were al-
tered. Indeed, flies overexpressing scylla and/or charyb-
dis showed significantly elevated lipid levels (Fig. 6C).
We also measured glycogen levels but could not detect
any statistically significant changes, although there was
a tendency toward increased glycogen content (data not
shown).
Discussion
Here we provide evidence that two related proteins,
Scylla and Charybdis, are negative modulators of Inr/
TOR signaling in response to different external stress
situations including hypoxia and starvation. scylla and
charybdis single mutants do not show obvious growth
phenotypes. scylla charybdis double-mutant flies are
also viable and fertile and exhibit a slight increase in
body size. Viability of the double mutants is strongly
reduced, however, when they are reared under hypoxic
conditions. Thus, although Scylla and Charybdis are
largely dispensable for normal development, they have a
critical role for the endurance of prolonged hypoxia. We
show that scylla is transcriptionally induced as a target
of Drosophila HIF-1 (the Tango–Similar dimer) and that
scylla and charybdis are up-regulated under hypoxic
conditions like their mammalian homolog RTP801/
REDD1. Furthermore, we show that Scylla negatively
regulates Inr/TOR signaling by reducing S6K but not
PKB activity.
scylla/charybdis and their orthologs are
stress-induced genes
RTP801 was described as a hypoxia/HIF-1-inducible fac-
tor with a role in apoptosis (Shoshani et al. 2002). We
Figure 6. Scylla and Charybdis prolong life span under starva-
tion conditions. (A) Homozygous char180 mutants are more sus-
ceptible to starvation than control animals. The average and
standard deviations of three independent experiments are
shown (n = 114 for char180/char180, m.; n = 145 for char180/+, m.;
n = 82 for char180/char180, f.; and n = 127 for char180/+, f.). (B)
Two- to three-day-old adult flies coexpressing scylla and
charybdis were starved, and survivors were counted every 4/8 h.
Simultaneous overexpression of both proteins strongly ex-
tended life span compared to control flies. A representative ex-
ample of three independent experiments is shown. (C) Ubiqui-
tous expression of scylla, charybdis, and/or both together using
the daGal4 driver is accompanied by elevated lipid levels in
males (left bar cluster) and females (right bar cluster; p < 0.065
for daGal4/EP1035, m.; for all other genotypes p < 0.0009;
n = 10). (m.) Males; (f.) females.
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find that scylla/charybdis, like their mammalian homo-
log, are induced by hypoxia, and that scylla is a direct
target of Drosophila HIF-1. However, we have no indi-
cation that scylla/charybdis overexpression promotes
cell death. Coexpression of the caspase inhibitors p35 or
DIAP1 did not rescue the small eye phenotype induced
by expression of either scylla or charybdis in the eye.
Moreover, acridine orange staining revealed no increased
cell death upon scylla/charybdis coexpression (data not
shown). Accordingly, we never observed signs of necrotic
eye tissue upon scylla/charybdis overexpression.
Dig2, a murine Scylla/Charybdis homolog, is also a
stress-responsive protein induced by a variety of treat-
ments including dexamethasone, thapsigargin, tunica-
mycin, and heat shock (Wang et al. 2003). Together with
the finding by Zinke et al. (2002) that scylla/charybdis
expression is increased during starvation conditions and
our analysis, showing that Scylla and Charybdis act as
growth inhibitors, these data support a model wherein
Scylla and Charybdis, induced by stresses like hypoxia
and starvation, act to dampen growth under certain
stress conditions.
Do Scylla and Charybdis act together?
Overexpressing either scylla or charybdis on their own
is sufficient to reduce growth. Coexpression of both
proteins seemed to have a slight cooperative effect (Fig.
1G) on the PKB/PDK1-dependent eye phenotype with
respect to ommatidial structure. Thus, an obvious ques-
tion is whether Scylla and Charybdis bind to each other
and exert their effect only in the presence of the other.
Notably, eye-specific charybdis overexpression in a
scylla−/− background resulted in the same phenotype as
in a wild-type situation (data not shown). This indicates
that Charybdis can act independently of Scylla. This
is further supported by their mostly nonoverlapping
mRNA expression patterns. Indeed, charybdis but not
scylla is expressed in neuromuscular junctions (M. Knirr
and C. Schuster, pers. comm.). Moreover, under hypoxia
only scylla was induced in the fat body but not charyb-
dis, indicating that they may be differentially regulated.
Scylla/Charybdis act downstream of PKB
but upstream of TSC to regulate S6K activity
Several lines of evidence indicate that Scylla and
Charybdis feed into the Inr pathway downstream of PKB:
(1) Scylla antagonizes PKB/PDK1-induced overgrowth in
the eye, but in vitro kinase assays demonstrate that
Scylla and Charybdis do not reduce PKB kinase activity,
nor does the loss of Scylla enhance PKB kinase activity.
(2) scylla or charybdis coexpression can rescue PKB-in-
duced developmental lethality, and ubiquitous scylla ex-
pression suppresses the lethality associated with hypo-
morphic PTEN mutants. (3) The weight reduction of
hypomorphic PKB3 flies is partially rescued by the si-
multaneous absence of Scylla function. (4) Eye-specific
PKB/PDK1 expression in a scylla−/− background leads to
a mild enhancement of the eye phenotype. (5) Overex-
pression of PTEN or Dp110DN does not suppress the big
eye phenotype of the tester system, suggesting that our
screening system identifies components that act down-
stream of PKB.
The S6K assay demonstrated that Scylla is capable of
reducing S6K activity. Thus, Scylla acts upstream of
S6K. This result is consistent with our in vivo results. (1)
scylla overexpression in the wing reduces wing size by
decreasing cell size but not cell number (in fact, cell
number is slightly increased), and (2) a S6K scylla mu-
tant combination has the same weight as S6K single mu-
tants. S6K mutants are smaller because of a reduction in
cell size but not cell number, making it distinct from
other Inr signaling pathway mutants (Montagne et al.
1999). Scylla and Charybdis do not control S6K activity
directly but require its upstream regulator TSC. Tsc1/2
mutants cannot be rescued by overexpression of scylla,
and the big head phenotype caused by loss of TSC func-
tion is not enhanced by the absence of Scylla and
Charybdis. Coexpression of scylla or charybdis and
Tsc1/2 does not further decrease eye size compared to
Tsc1 and Tsc2 co-overexpression on their own. More-
over, a Rheb-dependent big eye phenotype or lethality
induced by ubiquitous Rheb expression cannot be sup-
pressed by scylla expression. These results indicate that
Scylla regulates S6K activity by acting upstream of
Tsc1/2 and Rheb. This function appears to be conserved
between mammals and flies because RTP801/REDD1
can reduce S6 phosphorylation only in the presence of
TSC (Brugarolas et al. 2004).
Our findings indicate that scylla/charybdis overex-
pression mainly affects the TSC/TOR/S6K branch of the
pathway downstream of PKB. The PKB–FOXO axis ap-
pears not to be influenced by Scylla and Charybdis. Eye-
specific overexpression of scylla/charybdis in conjunc-
tion with FOXO was unable to induce 4EBP (Supplemen-
tary Fig. S2). In contrast, simultaneous expression of FOXO
and PTEN or a dominant-negative form of PI3K led to a
strong induction of the reporter gene (Junger et al. 2003).
Consistent with an interplay between the Inr and
TOR/S6K pathways, Inr lethality is suppressed by het-
erozygosity of Tsc1 (Gao and Pan 2001). Furthermore,
overexpressed PKB phosphorylates and inactivates Tsc2
and thereby activates S6K (Inoki et al. 2002; Manning et
al. 2002). Our finding that scylla overexpression is suffi-
cient to rescue the lethality associated with PKB over-
expression indicates that the lethality caused by PKB
overexpression is due to the hyperactivation of the TOR/
S6K pathway. Thus, oncogenic activation of PI3K/PKB
signaling seems to be mainly mediated by TOR/S6K sig-
naling. This may explain the beneficial effect of Rapa-
mycin treatment (or its derivatives CCl-779 and
RAD001) on PTEN-deficient tumors or cells overexpress-
ing PKB (Neshat et al. 2001; Podsypanina et al. 2001; Shi
et al. 2002; Majumder et al. 2004).
The TSC/TOR pathway as an integrator of growth
and metabolism
TSC and TOR receive multiple inputs reflecting the
metabolic state of the cell (Hay and Sonenberg 2004).
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AMP-activated kinase (AMPK) is a heterotrimeric kinase
that is activated by high AMP/ATP ratios in the cell
(Carling 2004). ATP depletion induces Tsc2-phosphory-
lation, and it was found that AMPK could interact with
and phosphorylate Tsc2 (Inoki et al. 2003b). Interest-
ingly, loss of Tsc2 in MEFs and U2OS osteosarcoma cells
under low serum and prolonged hypoxia conditions re-
sults in HIF-1 accumulation and concomitantly in-
creased expression of HIF-1 targets in a Rapamycin-de-
pendent manner (Brugarolas et al. 2003). Arsham et al.
(2003) showed that mTOR is regulated by decreased oxy-
gen concentration resulting in a dephosphorylation of
mTOR at Ser 2481, an mTOR autophosphorylation site.
This effect was accompanied by reduced S6K phosphory-
lation but did not correlate with changes in adenine
nucleotide levels and AMPK phosphorylation. Hence,
these findings suggest a role for AMPK/Tsc2/mTOR in
the integration of oxygen sensing/energy metabolism
and growth.
Model of Scylla/Charybdis function
Frei and Edgar (2004) found mutations in the gene en-
coding Drosophila HIF-1 prolyl hydroxylase (Hph), the
enzyme rendering HIF-1 a substrate for proteasomal de-
struction under normoxic conditions, as dominant sup-
pressors of a Cyclin D/Cdk4-induced bulging eye pheno-
type. Cells defective for hph show a growth deficit, and
its overexpression stimulated growth. The authors sug-
gested that the growth-promoting function of Hph is in-
dependent of HIF-1/Sima. Our results raise the possi-
bility that the Sima target scylla is important under hy-
poxia for growth inhibition.
We have shown that directed expression of Tgo–Sima
in the fat body induces scylla expression. That this regu-
lation is physiologically relevant can be inferred from
three findings. First, scylla is also induced under hypoxic
conditions. Second, directed expression of other bHLH-
PAS proteins like Tgo–Trh or Sim alone did not induce
scylla expression. Third, survival of flies lacking scylla
and charybdis function is severely compromised under
hypoxic conditions. Figure 7 summarizes our current
model of Scylla and Charybdis function. scylla and
charybdis are induced in response to external stress
stimuli (e.g., hypoxia and starvation) to inhibit growth
downstream of PKB but upstream of Tsc1/2. Scylla sup-
presses growth by reducing S6K activity. This could be
achieved by relieving the inhibitory effect of PKB on
Tsc2. Alternatively, Scylla/Charybdis could be nega-
tively regulated targets of PKB. This is unlikely, how-
ever, since Scylla and Charybdis lack PKB consensus
phosphorylation sites. AMPK, activated by drops in en-
ergy levels, may also contribute to the induction process
of scylla and charybdis for growth inhibition, presum-
ably under prolonged stress exposure. However, it is also
possible that AMPK is controlled by Scylla and/or
Charybdis. AMPK decreases protein synthesis by inhibi-
tion of S6K in a Rapamycin-sensitive manner, suggesting
that mTOR is involved in mediating AMPK signaling
(Kimura et al. 2003). AMPK also phosphorylates Tsc2, an
event important for the cellular energy response path-
way (Inoki et al. 2003b).
RTP801/REDD1 may act as a hypoxia-dependent
tumor suppressor
In tumors, hypoxic microenvironments are often en-
countered. Tumor hypoxia is associated with poor prog-
nosis and resistance to radiation-induced cell death. Mu-
tations in the tumor suppressor von Hippel-Lindau
(VHL), the subunit of an E3 ubiquitin ligase complex that
recognizes proline-hydroyxlated residues in HIF-1, lead
to the formation of a variety of tumors including clear
cell carcinomas of the kidney, pheochromocytomas, and
hemangioblastomas (Safran and Kaelin 2003). VHL-de-
fective tumors exhibit increased HIF-1 expression. The
induction of RTP801/REDD1 in cells exposed to hypoxia
in tumors raises the possibility that these genes may
play a role in tumor development. RTP801/REDD1 may
act as a tumor suppressor. Cells having lost RTP801/
REDD1 function may not stop growing under hypoxic
conditions and hence risk accumulating further muta-
tions that promote their tumorigenic state. The analysis
of RTP801/REDD1 expression or mutations in a variety
of tumor cell lines should help to test this hypothesis.
Materials and methods
EP element mapping and generation of transgenic flies
The insertion sites of EP9.85 and EPscy were determined by
plasmid rescue. To obtain UAS-scy, we PCR-amplified a frag-
ment containing the coding region of scylla out of a reverse-
transcribed embryonic RNA pool (kindly provided by K. Nairz,
University of Zurich, Switzerland); all primer sequences avail-
able on request). The PCR fragment was subcloned into the
pCRII-TOPO vector using the TOPO TA cloning kit (Invitro-
Figure 7. Model of scylla/charybdis regulation and their ef-
fects. scylla and charybdis are stress-induced, negative growth
modulators that inhibit growth under adverse environmental
conditions. They are likely to feed into Inr/TOR/S6K signaling
downstream of PKB but upstream of TSC to relieve the inhibi-
tory effect of PKB on the TSC complex, thereby inhibiting
growth. Our results do not exclude the possibility that S6K
activity also responds to stress independent of Scylla/Charybdis
function. Furthermore, Scylla/Charybdis may also regulate or
be regulated by AMPK. See text for details.
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gen). The scylla cDNA was cut out of pCRII-Topo as an Asp718/
XbaI fragment and inserted into the pUAST vector (Brand and
Perrimon 1993) to yield pJR3. At position 414 of the coding
region, our sequence differs from that submitted by S. Chauvet,
C. Maurel-Zaffran, R. Miassod, N. Julliens, J. Pradel, and D.
Aragnol (submitted sequence to the EMBL GenBank DDBJ da-
tabases) and results in an A → G exchange. However, the codon
still codes for Glu and represents either a silent mutation or a
polymorphism.
The shortened scylla construct UAS-scy1–12 was PCR-gen-
erated by using pJR3 as the DNA source with an ATG transla-
tional start site introduced by PCR mutagenesis. EP9.85, in-
serted 36 bp after the predicted translational start, shows the
same effects as EPscy, which lies further upstream of the scylla
transcription start site. We consider it likely that the last 3 nt of
EP9.85 (i.e., ATG) serve as starter methionine to which amino
acid 13 of the original Scylla protein is connected in frame.
To generate the UAS-char transgene, we ordered EST
LP03309 (Research Genetics) corresponding to charybdis and
checked the sequence for mutations. charybdis cDNA was ex-
cised from pOT2 as an EcoRI/XhoI fragment and inserted into
the pUAST vector.
Transgenic flies were generated by P element-mediated germ-
line transformation. Constructs were injected into y w embryos.
At least two independent lines could be established for each
construct.
Generation of mutants
For the generation of scylla mutants, we mobilized EP9.85
(marked with y+) inserted in the scylla ORF by supplying 2–3
transposase. Jump starter males were mated with y w; D/TM3
females, and single F1 y− males were crossed to y w; D/TM3
virgins. Approximately 400 stocks were established, and each
stock was molecularly investigated for deletions by single-fly
PCR using a panel of different primer pairs. Besides the men-
tioned scy31 and scy113 deletions, we found three additional
smaller deficiencies.
char180 was identified in a local hop screen, mobilizing the
original w+-marked EPchar insertion (causing a faint orange eye
color). After the mobilization, we scored animals having a
darker w+ eye color than EPchar and allowed recombination to
occur by crossing single females to y w males. Only lines in
which all the offspring consistently displayed the darker eye
color (i.e., where presumably no recombination has occurred)
were further analyzed by PCR using primers that would amplify
the charybdis genomic locus (but not when a new EP had in-
serted). Out of 331 single females showing a darker eye color,
112 lines were established and analyzed by single-fly PCR. Only
char180 was identified (contains the original EPchar element
plus a new inverted EP insertion [indicated as EP1035* in Fig.
1F] ∼450 bp upstream of the char ORF). Quantitative RT–PCR of
homozygous char180 flies revealed a 75% reduction in mRNA
levels (Q RT–PCR data available on request).
Fly stocks
The following fly stocks and transgenes have been used in the
course of this study: GMR-Gal4 (gift of M. Freeman, MRC Labo-
ratory of Molecular Biology, Cambridge, UK); UAS-PKB, UAS-
PDK1, EP837, and GMR > w+ > Gal4 (Rintelen et al. 2001);
UAS-PTEN (Huang et al. 1999); UAS-Dp110DN (Leevers et al.
1996); Act5CGal4, Lsp2Gal4, ZCL0611 (Scylla fly trap) and
Df(3L)vin4 (all from the Bloomington Drosophila Stock Center);
EP1035 (from the Szeged Drosophila Stock Center); eyflp;
FRT80 w+ cl3L/TM6B (Newsome et al. 2000); akt3 (Stocker et al.
2002); S6Kl-1/TM6B and S6K07084/TM6B (Montagne et al. 1999);
PTEN2L100/CyO, y+, and PTEN2L117/CyO, y+ (Oldham et al.
2000, 2002); PTENdj189/CyO, y+ (Gao et al. 2000); Tsc1Q87X/
TM6B, y+ (Tapon et al. 2001); Tsc12G3 (H. Stocker, unpubl.);
Tsc256/TM6B, y+, and Tsc2192/TM6B, y+ (Ito and Rubin 1999);
UAS-tgo, UAS-trh, and UAS-sim (gifts of B. Shilo, Department
of Molecular Genetics, Weizmann Institute of Science, Re-
hovot, Israel); UAS-sima692–863 (Lavista-Llanos et al. 2002);
daGal4/CyO (A. Wodarz, unpubl.); Thor1 (Bernal and Kimbrell
2000).
All crosses were performed at 25°C if not stated otherwise.
Phenotypic analyses
Freshly eclosed adult flies were collected, separated according to
sex, and placed for 24 h on normal fly food before weighing.
Weighing was performed using a Mettler Toledo MX5 micro-
balance.
scylla-overexpressing wings were mounted in Euparal
Mounting solution (TAAB Laboratories). Wing area was deter-
mined using Photoshop and NIH Image 1.61 to count pixels.
Relative cell number and cell size was determined by extrapo-
lating the counted hairs in a defined area (0.1 mm)2 on the dorsal
side of the wing proximal to the posterior cross-vein and poste-
rior to vein five.
Adult flies used for scanning electron microscopy were stored
in 70% acetone before they were critical-point dried and coated
with gold to be examined under the scanning microscope.
Adult fly heads were cut in half using a razor blade and
shortly stored in Ringers on ice. Eyes were then fixed as de-
scribed in Basler et al. (1991).
Heat-shock-induced Gal4 overexpression clones (y w hsflp;
GMR > w+ > Gal4, where > corresponds to FRT sites) were in-
duced 24–48 h after egg laying (AEL) by a 1-h heat shock at 37°C.
The heat shock induces FLP/FRT-mediated mitotic recombina-
tion leading to the excision of the w+ marker. scylla charybdis
double-mutant clones were induced 24–48 h AEL by a 30-min
heat shock at 38°C.
Starvation experiments and lipid analysis
Freshly eclosed flies were separated according to sex, left on
normal food for 2 d, and subsequently transferred to empty plas-
tic vials sealed with a water-soaked foam stopper. Dead flies
were counted every 4/8 h. Determination of lipid and glycogen
levels was done essentially as previously described (Bohni et al.
1999).
Hypoxia treatment
Larvae were exposed to the indicated O2 concentration at room
temperature or at 25°C in a closed chamber connected to a
gas-mixing pump (Digamix gas mixing pump, type M302 a-F, H
Wösthoff e.H.G) that mixes air and N2, or to a ventilation pump
(VENT2 pump, EMKA Technologies) that pushes a nitrogen/air
mixture into the chamber. Dissection and fixation of larval tis-
sues for mRNA in situ hybridizations and immunostainings
were carried out immediately after hypoxia exposure. Scylla
protein trap-larvae were dissected in Ringers, and larval tissue
was fixed in 4% paraformaldehyde/PBS for 1 h by gentle agita-
tion at room temperature. After a subsequent washing step,
nuclei were stained by incubation for 10 min in DAPI (0.5 µg/
mL)/PBS followed by three washing steps with PBS. Fluores-
cence images were recorded using a Zeiss Axiophot microscope.
mRNA in situ hybridizations were done essentially as de-
scribed (Lehmann and Tautz 1994; O’Neill and Bier 1994). In
vitro transcription was done using the DIG RNA labeling kit
(Roche). DNA fragments corresponding to parts of the scylla
SCY and CHAR inhibit S6K-mediated growth
GENES & DEVELOPMENT 2889
 on May 15, 2006 www.genesdev.orgDownloaded from 
and charybdis full-length mRNAs were PCR-amplified and sub-
cloned into pCRII-TOPO vector. For the in vitro transcription,
SP6 and T7 polymerases were used to produce sense and anti-
sense RNAs.
PKB-/S6K in vitro activity assays and Western blotting
PKB assay: For each sample, 50 heads of 2–3-d-old female flies
were removed with a forceps and collected on a cooled alumi-
num block placed on dry ice before the heads were transferred to
Eppendorf tubes and flash-frozen in liquid nitrogen. Heads were
squashed in 400 µL of extraction buffer (Stocker et al. 2003)
using a plastic pestle and subsequently treated as described pre-
viously (Radimerski et al. 2002b). One-hundred micrograms of
total protein was used for the PKB assay.
For the S6K assay, second instar larvae were collected by floa-
tation in 30% glycerol. Following a brief wash in water, batches
of 20–30 larvae were transferred to 1.5-mL Eppendorf tubes and
flash-frozen in liquid nitrogen. The S6K assay was done essen-
tially as described (Oldham et al. 2000). Either 25 or 40 µg of
total protein was used for the S6K assay with H2B (Histone type
VII-S, Sigma: H4255) as a substrate. Protein concentrations were
determined using the RC DC Protein Assay (Bio-Rad).
32P incorporation into Crosstide or H2B was quantified and
background-corrected using a PhosphorImager and image-quant
software (Molecular Dynamics).
Western blotting: The following antibodies and dilutions
were used: S6K D-20 antibody (Montagne et al. 1999) at 1:200
dilution, PKB antibody (Andjelkovic et al. 1995) at 1:1000 and
mouse anti--tubulin (Sigma) at 1:2000. HRP-conjugated sec-
ondary antibodies (Dako A/S, Glostrup) were diluted 1:2000.
Since the same PKB antibody used in immunoprecipitation was
also used in Western blotting, HRP-conjugated protein-A (ICN
Biomedicals) at 1:5000 was used instead of secondary antibody.
Signals were detected using ECL Western blotting detection re-
agents (Amersham Biosciences).
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